Annual EBITDA
-$20.16 M
+$19.83 M+49.59%
December 31, 2023
Summary
- As of February 8, 2025, WINT annual EBITDA is -$20.16 million, with the most recent change of +$19.83 million (+49.59%) on December 31, 2023.
- During the last 3 years, WINT annual EBITDA has risen by +$12.11 million (+37.54%).
- WINT annual EBITDA is now -907.95% below its all-time high of -$2.00 million, reached on December 31, 1995.
Performance
WINT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.81 M
+$8.68 M+75.53%
September 30, 2024
Summary
- As of February 8, 2025, WINT quarterly EBITDA is -$2.81 million, with the most recent change of +$8.68 million (+75.53%) on September 30, 2024.
- Over the past year, WINT quarterly EBITDA has increased by +$1.49 million (+34.66%).
- WINT quarterly EBITDA is now -127.11% below its all-time high of $10.37 million, reached on March 31, 2024.
Performance
WINT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$9.07 M
+$1.49 M+14.11%
September 30, 2024
Summary
- As of February 8, 2025, WINT TTM EBITDA is -$9.07 million, with the most recent change of +$1.49 million (+14.11%) on September 30, 2024.
- Over the past year, WINT TTM EBITDA has increased by +$16.68 million (+64.76%).
- WINT TTM EBITDA is now -2924.67% below its all-time high of -$300.00 thousand, reached on March 31, 1995.
Performance
WINT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
WINT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +49.6% | +34.7% | +64.8% |
| 3 y3 years | +37.5% | +31.0% | +75.1% |
| 5 y5 years | -6.3% | +31.0% | +75.1% |
WINT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +73.9% | -127.1% | +83.8% | -67.1% | +88.3% |
| 5 y | 5-year | at high | +73.9% | -127.1% | +93.8% | -67.1% | +88.3% |
| alltime | all time | -908.0% | +73.9% | -127.1% | +93.8% | -2924.7% | +88.3% |
Windtree Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.81 M(-75.5%) | -$9.07 M(-14.1%) |
| Jun 2024 | - | -$11.49 M(-210.8%) | -$10.56 M(+94.6%) |
| Mar 2024 | - | $10.37 M(-301.6%) | -$5.43 M(-72.7%) |
| Dec 2023 | -$20.16 M(-49.6%) | -$5.14 M(+19.5%) | -$19.87 M(-22.8%) |
| Sep 2023 | - | -$4.30 M(-32.3%) | -$25.75 M(+1.1%) |
| Jun 2023 | - | -$6.35 M(+55.8%) | -$25.47 M(-30.1%) |
| Mar 2023 | - | -$4.08 M(-63.0%) | -$36.42 M(-8.9%) |
| Dec 2022 | -$39.99 M(-48.3%) | -$11.02 M(+174.1%) | -$39.99 M(-8.3%) |
| Sep 2022 | - | -$4.02 M(-76.8%) | -$43.63 M(-8.6%) |
| Jun 2022 | - | -$17.30 M(+126.2%) | -$47.76 M(-37.2%) |
| Mar 2022 | - | -$7.65 M(-47.8%) | -$76.09 M(-1.6%) |
| Dec 2021 | -$77.32 M(+139.6%) | -$14.66 M(+79.9%) | -$77.32 M(+10.4%) |
| Sep 2021 | - | -$8.15 M(-82.1%) | -$70.06 M(-1.1%) |
| Jun 2021 | - | -$45.63 M(+414.1%) | -$70.84 M(+104.2%) |
| Mar 2021 | - | -$8.88 M(+19.8%) | -$34.70 M(+7.5%) |
| Dec 2020 | -$32.27 M(+20.5%) | -$7.41 M(-17.1%) | -$32.27 M(+0.6%) |
| Sep 2020 | - | -$8.93 M(-5.8%) | -$32.09 M(+6.5%) |
| Jun 2020 | - | -$9.48 M(+47.1%) | -$30.14 M(+12.1%) |
| Mar 2020 | - | -$6.45 M(-10.7%) | -$26.88 M(+0.4%) |
| Dec 2019 | -$26.79 M(+41.2%) | -$7.22 M(+3.4%) | -$26.79 M(-3.7%) |
| Sep 2019 | - | -$6.98 M(+12.1%) | -$27.80 M(+14.7%) |
| Jun 2019 | - | -$6.23 M(-1.9%) | -$24.25 M(+15.8%) |
| Mar 2019 | - | -$6.35 M(-22.9%) | -$20.93 M(+10.4%) |
| Dec 2018 | -$18.96 M(+15.7%) | -$8.24 M(+140.3%) | -$18.96 M(+130.6%) |
| Sep 2018 | - | -$3.43 M(+17.4%) | -$8.22 M(-13.8%) |
| Jun 2018 | - | -$2.92 M(-33.4%) | -$9.54 M(-25.0%) |
| Mar 2018 | - | -$4.38 M(-275.0%) | -$12.71 M(-22.4%) |
| Dec 2017 | -$16.39 M(-55.4%) | $2.50 M(-152.8%) | -$16.39 M(-34.0%) |
| Sep 2017 | - | -$4.75 M(-22.1%) | -$24.83 M(-10.5%) |
| Jun 2017 | - | -$6.09 M(-24.4%) | -$27.74 M(-12.1%) |
| Mar 2017 | - | -$8.06 M(+35.8%) | -$31.57 M(-14.0%) |
| Dec 2016 | -$36.72 M(-26.4%) | -$5.93 M(-22.5%) | -$36.72 M(-8.6%) |
| Sep 2016 | - | -$7.66 M(-22.8%) | -$40.18 M(-23.5%) |
| Jun 2016 | - | -$9.92 M(-24.8%) | -$52.52 M(-0.0%) |
| Mar 2016 | - | -$13.20 M(+40.4%) | -$52.53 M(+5.3%) |
| Dec 2015 | -$49.88 M(+29.1%) | -$9.40 M(-53.0%) | -$49.87 M(+0.4%) |
| Sep 2015 | - | -$20.00 M(+101.4%) | -$49.66 M(+25.4%) |
| Jun 2015 | - | -$9.93 M(-5.8%) | -$39.62 M(+1.7%) |
| Mar 2015 | - | -$10.55 M(+14.7%) | -$38.95 M(+0.8%) |
| Dec 2014 | -$38.64 M(-10.2%) | -$9.19 M(-7.6%) | -$38.64 M(-4.4%) |
| Sep 2014 | - | -$9.95 M(+7.3%) | -$40.41 M(-4.2%) |
| Jun 2014 | - | -$9.27 M(-9.4%) | -$42.16 M(+2.8%) |
| Mar 2014 | - | -$10.23 M(-6.6%) | -$41.01 M(-4.7%) |
| Dec 2013 | -$43.04 M(+19.2%) | -$10.96 M(-6.3%) | -$43.04 M(-1.4%) |
| Sep 2013 | - | -$11.70 M(+44.1%) | -$43.64 M(+4.7%) |
| Jun 2013 | - | -$8.12 M(-33.8%) | -$41.66 M(+3.1%) |
| Mar 2013 | - | -$12.26 M(+6.0%) | -$40.39 M(+6.7%) |
| Dec 2012 | -$36.11 M(+83.2%) | -$11.57 M(+19.0%) | -$37.86 M(+33.6%) |
| Sep 2012 | - | -$9.72 M(+42.0%) | -$28.34 M(+15.8%) |
| Jun 2012 | - | -$6.85 M(-29.6%) | -$24.48 M(+3.3%) |
| Mar 2012 | - | -$9.72 M(+374.3%) | -$23.69 M(+20.2%) |
| Dec 2011 | -$19.70 M(+14.1%) | -$2.05 M(-65.0%) | -$19.70 M(+18.4%) |
| Sep 2011 | - | -$5.86 M(-3.3%) | -$16.64 M(+0.0%) |
| Jun 2011 | - | -$6.06 M(+5.7%) | -$16.64 M(+1.3%) |
| Mar 2011 | - | -$5.74 M(-665.0%) | -$16.42 M(-4.9%) |
| Dec 2010 | -$17.27 M(-36.5%) | $1.01 M(-117.3%) | -$17.27 M(-27.1%) |
| Sep 2010 | - | -$5.86 M(+0.2%) | -$23.70 M(-2.5%) |
| Jun 2010 | - | -$5.85 M(-11.2%) | -$24.30 M(-5.1%) |
| Mar 2010 | - | -$6.58 M(+21.6%) | -$25.60 M(-5.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | -$27.20 M(-24.8%) | -$5.41 M(-16.2%) | -$27.20 M(-7.9%) |
| Sep 2009 | - | -$6.46 M(-9.7%) | -$29.55 M(-10.3%) |
| Jun 2009 | - | -$7.15 M(-12.7%) | -$32.95 M(-6.5%) |
| Mar 2009 | - | -$8.19 M(+5.5%) | -$35.25 M(-2.6%) |
| Dec 2008 | -$36.18 M(-4.5%) | -$7.76 M(-21.2%) | -$36.18 M(-9.0%) |
| Sep 2008 | - | -$9.86 M(+4.3%) | -$39.75 M(+2.5%) |
| Jun 2008 | - | -$9.45 M(+3.7%) | -$38.79 M(-1.0%) |
| Mar 2008 | - | -$9.11 M(-19.6%) | -$39.20 M(+3.5%) |
| Dec 2007 | -$37.88 M(-7.7%) | -$11.33 M(+27.3%) | -$37.88 M(+11.0%) |
| Sep 2007 | - | -$8.90 M(-9.7%) | -$34.13 M(+3.7%) |
| Jun 2007 | - | -$9.85 M(+26.3%) | -$32.92 M(+0.5%) |
| Mar 2007 | - | -$7.80 M(+3.0%) | -$32.76 M(-20.2%) |
| Dec 2006 | -$41.04 M(-1.6%) | -$7.57 M(-1.5%) | -$41.04 M(-10.9%) |
| Sep 2006 | - | -$7.69 M(-20.7%) | -$46.04 M(-5.3%) |
| Jun 2006 | - | -$9.70 M(-39.7%) | -$48.62 M(-0.1%) |
| Mar 2006 | - | -$16.08 M(+27.9%) | -$48.69 M(+16.7%) |
| Dec 2005 | -$41.72 M(+12.5%) | -$12.57 M(+22.4%) | -$41.72 M(+2.2%) |
| Sep 2005 | - | -$10.27 M(+5.2%) | -$40.81 M(+5.9%) |
| Jun 2005 | - | -$9.77 M(+7.1%) | -$38.52 M(+2.8%) |
| Mar 2005 | - | -$9.12 M(-21.8%) | -$37.47 M(+1.0%) |
| Dec 2004 | -$37.09 M(+54.4%) | -$11.66 M(+46.0%) | -$37.09 M(+11.0%) |
| Sep 2004 | - | -$7.98 M(-8.4%) | -$33.41 M(+5.4%) |
| Jun 2004 | - | -$8.71 M(-0.2%) | -$31.70 M(+14.9%) |
| Mar 2004 | - | -$8.73 M(+9.5%) | -$27.59 M(+17.5%) |
| Dec 2003 | -$24.02 M(+35.4%) | -$7.98 M(+27.1%) | -$23.48 M(+17.8%) |
| Sep 2003 | - | -$6.27 M(+36.0%) | -$19.93 M(+8.3%) |
| Jun 2003 | - | -$4.61 M(-0.1%) | -$18.39 M(+2.6%) |
| Mar 2003 | - | -$4.62 M(+4.4%) | -$17.94 M(+6.6%) |
| Dec 2002 | -$17.74 M(+50.9%) | -$4.42 M(-6.7%) | -$16.82 M(+4.4%) |
| Sep 2002 | - | -$4.74 M(+14.1%) | -$16.11 M(+16.5%) |
| Jun 2002 | - | -$4.16 M(+18.7%) | -$13.82 M(+11.1%) |
| Mar 2002 | - | -$3.50 M(-5.7%) | -$12.44 M(+10.1%) |
| Dec 2001 | -$11.76 M(-0.2%) | -$3.71 M(+51.0%) | -$11.30 M(-21.6%) |
| Sep 2001 | - | -$2.46 M(-11.3%) | -$14.42 M(+6.1%) |
| Jun 2001 | - | -$2.77 M(+17.4%) | -$13.59 M(+4.5%) |
| Mar 2001 | - | -$2.36 M(-65.4%) | -$13.01 M(+7.6%) |
| Dec 2000 | -$11.78 M(+134.3%) | -$6.83 M(+319.0%) | -$12.09 M(+83.6%) |
| Sep 2000 | - | -$1.63 M(-25.5%) | -$6.59 M(+18.5%) |
| Jun 2000 | - | -$2.19 M(+51.5%) | -$5.56 M(+21.7%) |
| Mar 2000 | - | -$1.44 M(+9.0%) | -$4.57 M(-10.2%) |
| Dec 1999 | -$5.03 M(-34.7%) | -$1.32 M(+120.8%) | -$5.09 M(-13.2%) |
| Sep 1999 | - | -$600.00 K(-50.0%) | -$5.86 M(-9.3%) |
| Jun 1999 | - | -$1.20 M(-38.9%) | -$6.46 M(-14.6%) |
| Mar 1999 | - | -$1.96 M(-6.5%) | -$7.56 M(-3.0%) |
| Dec 1998 | -$7.70 M(+24.2%) | -$2.10 M(+75.0%) | -$7.80 M(-25.7%) |
| Sep 1998 | - | -$1.20 M(-47.8%) | -$10.50 M(+11.7%) |
| Jun 1998 | - | -$2.30 M(+4.5%) | -$9.40 M(+1.1%) |
| Mar 1998 | - | -$2.20 M(-54.2%) | -$9.30 M(+20.8%) |
| Dec 1997 | -$6.20 M(+169.5%) | -$4.80 M(+4699.0%) | -$7.70 M(+108.1%) |
| Sep 1997 | - | -$100.00 K(-95.5%) | -$3.70 M(-14.0%) |
| Jun 1997 | - | -$2.20 M(+266.7%) | -$4.30 M(+79.2%) |
| Mar 1997 | - | -$600.00 K(-25.0%) | -$2.40 M(+9.1%) |
| Dec 1996 | -$2.30 M(+15.0%) | -$800.00 K(+14.3%) | -$2.20 M(-43.6%) |
| Sep 1996 | - | -$700.00 K(+133.3%) | -$3.90 M(+25.8%) |
| Jun 1996 | - | -$300.00 K(-25.0%) | -$3.10 M(-16.2%) |
| Mar 1996 | - | -$400.00 K(-84.0%) | -$3.70 M(+2.8%) |
| Dec 1995 | -$2.00 M | -$2.50 M(-2600.0%) | -$3.60 M(+227.3%) |
| Sep 1995 | - | $100.00 K(-111.1%) | -$1.10 M(-8.3%) |
| Jun 1995 | - | -$900.00 K(+200.0%) | -$1.20 M(+300.0%) |
| Mar 1995 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Windtree Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Windtree Therapeutics?
- What is Windtree Therapeutics annual EBITDA year-on-year change?
- What is Windtree Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Windtree Therapeutics?
- What is Windtree Therapeutics quarterly EBITDA year-on-year change?
- What is Windtree Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Windtree Therapeutics?
- What is Windtree Therapeutics TTM EBITDA year-on-year change?
What is Windtree Therapeutics annual EBITDA?
The current annual EBITDA of WINT is -$20.16 M
What is the all time high annual EBITDA for Windtree Therapeutics?
Windtree Therapeutics all-time high annual EBITDA is -$2.00 M
What is Windtree Therapeutics annual EBITDA year-on-year change?
Over the past year, WINT annual EBITDA has changed by +$19.83 M (+49.59%)
What is Windtree Therapeutics quarterly EBITDA?
The current quarterly EBITDA of WINT is -$2.81 M
What is the all time high quarterly EBITDA for Windtree Therapeutics?
Windtree Therapeutics all-time high quarterly EBITDA is $10.37 M
What is Windtree Therapeutics quarterly EBITDA year-on-year change?
Over the past year, WINT quarterly EBITDA has changed by +$1.49 M (+34.66%)
What is Windtree Therapeutics TTM EBITDA?
The current TTM EBITDA of WINT is -$9.07 M
What is the all time high TTM EBITDA for Windtree Therapeutics?
Windtree Therapeutics all-time high TTM EBITDA is -$300.00 K
What is Windtree Therapeutics TTM EBITDA year-on-year change?
Over the past year, WINT TTM EBITDA has changed by +$16.68 M (+64.76%)